Managing a post-pandemic supply chain in healthcare
In 2020, healthcare distributors delivered over 51 billion personal protective equipment (PPE) supplies to providers on the frontlines of the fight against COVID-19.
BALTIMORE, MD, January 17, 2025 – INFORMS, the world’s largest association for professionals and students in operations research (O.R.), AI, analytics and data science, has unveiled six finalists for the prestigious 2025 Franz Edelman Award for achievement in advanced analytics, operations research and management science. Recognized as the pinnacle of achievement in the application of analytics and operations research, the award, often referred to as “The Nobel Prize” of O.R. and advanced analytics, celebrates groundbreaking research and innovations that are transforming industries, improving lives and shaping a smarter, more sustainable future.
Cutting-edge chips, especially those designed to power emerging AI applications, tend to receive the most attention in the media and generate the most excitement. However, so-called “legacy” chips are just as important — if not more — to our daily lives.
January is National Blood Donor Month and, not coincidentally, a time when donations tend to ebb. Every two seconds, someone in the U.S. needs blood for serious injuries, childbirth, cancer treatments and more, according to the Department of Health and Human Services.
An audio journey of how data and analytics save lives, save money and solve problems.
Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578
Explore our resources for multiple topics including:
In 2020, healthcare distributors delivered over 51 billion personal protective equipment (PPE) supplies to providers on the frontlines of the fight against COVID-19.
Over 30 million adults have opted to take a pass on the COVID-19 vaccines, including around 3 million people over 65 years-old. They are exercising their personal choice to remain unprotected against the virus through vaccination, choosing to accept the associated risks.
Pfizer/BioNTech and Moderna have both begun clinical trials with an omicron-specific vaccine. Sounds good in theory, given that the majority of infections in the United States are with the omicron variant. However, there are numerous reason why such a product will not provide any additional benefits beyond the vaccines that are already available.
A family member became seriously ill last year. After some initial tests, a malignancy was diagnosed. Surgery was scheduled, followed by chemotherapy. Everything proceeded mostly as planned, with no medical hiccups. We are both well-educated, with backgrounds in medicine, health economics and risk analysis, which should have prepared us to maneuver the requirements of our health insurance provider and ensure that copays and pre- authorizations were handled as necessary. We were gravely mistaken.
Surprisingly, a new study has found that if you’re perceived as more popular on a mobile dating app, there is a higher chance that other users will avoid connecting with you. This is one of the major findings of a study that sought to examine the effect of a dating app user’s popularity rating on their demand on the online dating platform.
OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today MagazineAnalytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine